Stryker (SYK) Competitors $376.50 -4.36 (-1.14%) As of 01:50 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SYK vs. CSQ, ISRG, BSX, CAH, COR, DVA, MDT, ZBH, ABT, and BDXShould you be buying Stryker stock or one of its competitors? The main competitors of Stryker include Calamos Strategic Total Return Fund (CSQ), Intuitive Surgical (ISRG), Boston Scientific (BSX), Cardinal Health (CAH), Cencora (COR), DaVita (DVA), Medtronic (MDT), Zimmer Biomet (ZBH), Abbott Laboratories (ABT), and Becton, Dickinson and Company (BDX). Stryker vs. Its Competitors Calamos Strategic Total Return Fund Intuitive Surgical Boston Scientific Cardinal Health Cencora DaVita Medtronic Zimmer Biomet Abbott Laboratories Becton, Dickinson and Company Stryker (NYSE:SYK) and Calamos Strategic Total Return Fund (NASDAQ:CSQ) are related companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, institutional ownership, earnings, analyst recommendations, valuation and risk. Do analysts recommend SYK or CSQ? Stryker currently has a consensus target price of $430.10, indicating a potential upside of 14.24%. Given Stryker's stronger consensus rating and higher probable upside, research analysts clearly believe Stryker is more favorable than Calamos Strategic Total Return Fund.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Stryker 0 Sell rating(s) 4 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 2.79Calamos Strategic Total Return Fund 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has preferable earnings and valuation, SYK or CSQ? Stryker has higher revenue and earnings than Calamos Strategic Total Return Fund. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStryker$22.60B6.37$2.99B$7.5549.87Calamos Strategic Total Return Fund$280.21MN/AN/AN/AN/A Does the media refer more to SYK or CSQ? In the previous week, Stryker had 51 more articles in the media than Calamos Strategic Total Return Fund. MarketBeat recorded 52 mentions for Stryker and 1 mentions for Calamos Strategic Total Return Fund. Stryker's average media sentiment score of 1.17 beat Calamos Strategic Total Return Fund's score of 1.00 indicating that Stryker is being referred to more favorably in the media. Company Overall Sentiment Stryker Positive Calamos Strategic Total Return Fund Positive Is SYK or CSQ a better dividend stock? Stryker pays an annual dividend of $3.36 per share and has a dividend yield of 0.9%. Calamos Strategic Total Return Fund pays an annual dividend of $1.23 per share and has a dividend yield of 6.8%. Stryker pays out 44.5% of its earnings in the form of a dividend. Stryker has raised its dividend for 32 consecutive years. Do institutionals and insiders hold more shares of SYK or CSQ? 77.1% of Stryker shares are owned by institutional investors. 5.2% of Stryker shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is SYK or CSQ more profitable? Stryker has a net margin of 12.25% compared to Calamos Strategic Total Return Fund's net margin of 0.00%. Stryker's return on equity of 23.94% beat Calamos Strategic Total Return Fund's return on equity.Company Net Margins Return on Equity Return on Assets Stryker12.25% 23.94% 11.08% Calamos Strategic Total Return Fund N/A N/A N/A SummaryStryker beats Calamos Strategic Total Return Fund on 12 of the 14 factors compared between the two stocks. Get Stryker News Delivered to You Automatically Sign up to receive the latest news and ratings for SYK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SYK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SYK vs. The Competition Export to ExcelMetricStrykerMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$143.96B$10.37B$5.48B$20.66BDividend Yield0.88%2.00%4.71%3.67%P/E Ratio49.8819.0628.7329.26Price / Sales6.3728.45439.6661.43Price / Cash25.2922.1035.6823.31Price / Book6.793.508.154.42Net Income$2.99B$211.77M$3.25B$995.90M7 Day Performance-6.06%-0.19%-0.99%-0.16%1 Month Performance-3.95%3.14%5.25%-0.69%1 Year Performance16.69%-10.48%28.32%15.58% Stryker Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SYKStryker4.9189 of 5 stars$376.50-1.1%$430.10+14.2%+20.6%$143.96B$22.60B49.8853,000Positive NewsEarnings ReportAnalyst ForecastCSQCalamos Strategic Total Return FundN/A$18.49-0.4%N/A+15.3%$0.00$280.21M0.00N/APositive NewsDividend AnnouncementISRGIntuitive Surgical4.7597 of 5 stars$494.30-0.3%$592.05+19.8%+8.9%$177.04B$8.35B68.8815,638Positive NewsBSXBoston Scientific4.5615 of 5 stars$105.93-0.2%$117.50+10.9%+43.5%$156.71B$18.49B63.0553,000Positive NewsInsider TradeCAHCardinal Health4.7033 of 5 stars$156.09-0.7%$158.07+1.3%+60.9%$37.26B$226.83B24.3548,900Positive NewsUpcoming EarningsCORCencora4.4782 of 5 stars$286.01-1.5%$309.83+8.3%+21.1%$55.40B$293.96B33.1646,000Trending NewsEarnings ReportDividend AnnouncementGap DownDVADaVita4.744 of 5 stars$145.42+0.2%$167.40+15.1%+4.1%$10.98B$12.82B14.4176,000Trending NewsEarnings ReportGap DownMDTMedtronic4.637 of 5 stars$92.11-0.9%$98.19+6.6%+11.6%$118.18B$33.54B25.4695,000Positive NewsZBHZimmer Biomet4.6627 of 5 stars$95.96-1.6%$111.39+16.1%-14.1%$18.98B$7.70B21.2317,000News CoveragePositive NewsUpcoming EarningsABTAbbott Laboratories4.9786 of 5 stars$126.18-0.3%$144.47+14.5%+20.4%$219.16B$41.95B15.78114,000Positive NewsBDXBecton, Dickinson and Company4.4487 of 5 stars$183.40-1.0%$219.22+19.5%-25.0%$52.58B$20.18B35.0174,000Positive NewsUpcoming Earnings Related Companies and Tools Related Companies CSQ Alternatives ISRG Alternatives BSX Alternatives CAH Alternatives COR Alternatives DVA Alternatives MDT Alternatives ZBH Alternatives ABT Alternatives BDX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SYK) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredGuess Who the Gvt Could Partner With Next?The Government Just Made a $400M Bet. Who's Next? A $100 trillion wealth shift is quietly underway... and t...Stansberry Research | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stryker Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Stryker With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
